TY - JOUR
T1 - EUropean REcommendations for female FERtility preservation (EU-REFER)
T2 - A joint collaboration between oncologists and fertility specialists
AU - Dolmans, Marie Madeleine
AU - Lambertini, Matteo
AU - Macklon, Kirsten Tryde
AU - Almeida Santos, Teresa
AU - Ruiz-Casado, Ana
AU - Borini, Andrea
AU - Bordes, Virginie
AU - Frith, Lucy
AU - Van Moer, Ellen
AU - Germeyer, Ariane
N1 - Funding Information:
The authors thank Rachel Hutchings, PhD, BPharm (Hons) for medical writing and editorial assistance, which was funded by Teva/Theramex.
Funding Information:
This work was funded by Teva Pharmaceuticals Europe, Women's Health Division (now Theramex HQ UK Limited).
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/6
Y1 - 2019/6
N2 - In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.
AB - In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.
KW - Expert recommendations
KW - Female cancer patients
KW - Fertility preservation
KW - Haematologists
KW - Oncofertility
KW - Oncologists
UR - http://www.scopus.com/inward/record.url?scp=85065496993&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2019.03.010
DO - 10.1016/j.critrevonc.2019.03.010
M3 - Review article
C2 - 31092380
AN - SCOPUS:85065496993
SN - 1040-8428
VL - 138
SP - 233
EP - 240
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
ER -
